Guangzhou Jinan University Pharmaceutical Biotechnology Research and Development Center Co., Ltd., established on 1999-07-08, The scope of business includes food science and technology research services;drug development;Medical Research and Experimental Development;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);laboratory testing(Those involving licensed projects need to obtain a license before they can engage in business operations);Biological Products Testing;Chemical product testing service;

The Population Council is an international, nonprofit, non-governmental organization. The Council conducts research in biomedicine, social science, and public health and helps build research capacities in developing countries. One-third of its research relates to HIV and AIDS; while its other major program areas are in reproductive health and its relation to poverty, youth, and gender. For example, the Population Council strives to teach boys that they can be involved in contraceptive methods regardless of stereotypes that limit male responsibility in child bearing. The organization held the license for Norplant contraceptive implant, and now holds the license for Mirena intrauterine system. The Population Council also publishes the journal Population and Development Review, which reports scientific research on the interrelationships between population and socioeconomic development. It also provides a forum for discussion on related issues of public policy and Studies in Family Planning, which focuses on public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning.

Tama Biochemical Co. Ltd. is a Japanese private company that manufactures pharmaceuticals, nutraceuticals and food additives.

Pantarhei Bioscience BV (PRB) is a limited liability company (Besloten Vennootschap) located in the Netherlands focussing on the development of innovative concepts for woman’s health and hormone-related cancer treatments. PRB has founded a subsidiary company – Pantarhei Oncology (PRO) – to develop treatments for Endocrine Cancer. PRB has developed a product pipeline based on its ability to identify novel medical uses of existing molecules, drugs, hormones, biologicals and combinations thereof in these areas of medicine. The main areas of expertise of PRB are reproductive hormone related treatments and diseases such as contraception and menopausal hormone therapy (MHT). The main areas of expertise of PRO are breast cancer, prostate cancer and ovarian cancer . PRB develops patent protected new treatment concepts up to proof-of-concept (PoC) in the human (phase II). Using existing molecules often provides first evidence of safety. The business model of the Pantarhei companies is based on creating intellectual property (IP) of new concepts ad inventions, in-house project management and outsourcing of all research and development activities. After successful PoC, data and IP are licensed out to a licensee or partner for completion of clinical development (phase III), regulatory approval and sales and marketing by a licensee/partner.

Jilin Northeast Asia Biotechnology Co., Ltd., established on 2012-10-26, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Mechanical equipment research and development;Machinery sales;Chinese herbal medicine planting;Conference and Exhibition Services;internet sales(Except for products that require a license for sale);Cosmetics Retail.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food production;Cosmetic production;pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Guangzhou Sidanfu Biotechnology Co., Ltd., established on 2011-07-15, Business scope includes biotechnology extension services;Biotechnology Development Services;Investment Advisory Services;Technology Import and Export;Import and export(Excluding franchised products);Commodity retail trade(Except for licensed and approved products);Commodity wholesale trade(Except for licensed and approved products);

Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA.

Hangzhou Yihaixuan Biotechnology Co., Ltd., established on 2012-07-25, The business scope includes biochemical reagents,Clinical Diagnostic Reagents,Medical device products,Biochemical test supplies,genetic engineering technology,Research and development of microbial environmental protection products,Technical Services;Sales:Chemical raw materials(Removal of hazardous chemicals and precursor chemicals).

Shenzhen Lailisai Biological Technology Co., Ltd., established on 2017-03-21, Business scope includes general business items:Engaged in technology development in the field of biotechnology,Technical Services,technical consulting,technology transfer;Domestic Trade;New products in the field of biotechnology,New Technology,Research and development of new technologies and industrialization of results;Basic research and application of biomedical technology;Cosmetic production,Cosmetics research and development and cosmetics sales.(above according to the law,Administrative regulations,Decisions of the State Council and other regulations that require approval,Can only operate after obtaining relevant approval documents according to law).Sales of Class I Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Biological and chemical reagents,Production of consumables,operate.

Tianjin Yibeiyuan Natural Product Technology Co., Ltd., established on 2017-02-28, Business scope includes general items:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Food import and export;Import and export;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Food Additive Sales;Engineering and Technology Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)